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Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRF.
Chronic renal failure (CRF) is associated with an increase in calcium
content of heart. This was attributed to the secondary hyperparathy-
roidism of CRF, since PTH augments entry of calcium into cardiac
myocytes. At present, it is not known whether the increase in calcium
content of heart reflects a rise in basal levels of cytosolic calcium
([Ca2]) of cardiac myocytes. Further, in order for the PTH-induced
entry of calcium into cardiac myocytes to raise their basal levels of
[Ca2], calcium extrusion out of these cells should be impaired as well.
The present study examined the effect of CRF with and without excess
PTH (PTX) and of the treatment of CRF rats with verapamil on basal
levels of [Ca2], and ATP content of cardiac myocytes and on the
activities of the pumps that are directly (Ca2-ATPase and Na-Ca2
exchanger) and indirectly (Na-K ATPase) responsible for calcium
extrusion out of these cells. The basal levels of [Ca]1 of cardiac
myocytes increased (P < 0.01) and their ATP content decreased (P <
0.01) as the duration of CRF advanced. CRF was associated with
significant decrement in V,,, of Ca2 ATPase and Na-KATPase and
in Na-Ca2 exchange. These derangements were prevented by prior
PTX of the CRF rats or by their treatment with verapamil. The data
indicate that (1) CRF is associated with a significant rise in basal levels
of [Ca2] of cardiac myocytes, (2) this effect is mediated by the state of
secondary hyperparathyroidism of CRF, and (3) the pathways through
which excess VFH in CRF generates this effect include both increased
entry of calcium into cardiac myocytes and decreased exit of this ion
out of these cells.
The heart is a target organ for PTH in that the hormone
stimulates the generation of cyclic AMP by cardiac myocytes
[1], increases their beating rate [1] and raises their cytosolic
calcium ([Ca2]1) [2]. The hormone also increases the contrac-
tile force of the cardiac auricles [3].
Animals with chronic renal failure (CRF) display an increase
in calcium content of their hearts [4] and an impairment in
mitochondrial oxidation [4, 5] and fatty acid utilization by their
myocardium [6]. These derangements were attributed to the
state of secondary hyperparathyroidism of CRF since the
removal of the parathyroid glands of these animals prior to the
induction of CRF prevented these derangements [4, 6]. Also,
evidence exists pointing toward a role for excess PTH in the
genesis of cardiac myopathy in patients with CRF [7—9] and in
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patients with elevated blood levels of PTH even though their
renal function is normal [10—12].
It is postulated that the derangements in myocardial function
and metabolism in CRF is due to a sustained elevation in [Ca2]1
of cardiac myocytes since high levels of [Ca2]1 in other cell
types were associated with significant disturbances in their
function [13—17]. If an elevation in [Ca2]1 of cardiac myocytes
develops in CRF, it would be most likely mediated by the ability
of PTH to augment entry of calcium into these cells [2].
However, an increase in calcium entry into cells should not
result in elevation in their [Ca2]1 unless the processes respon-
sible for calcium removal from the cytosol are also impaired in
CRF.
The present study examined whether CRF is associated with
an elevation in basal levels of [Ca2]1 of cardiac myocytes,
whether such an abnormality is mediated by the state of
secondary hyperparathyroidism of CRF, and whether the pro-
cesses involved in calcium extrusion out of these cells are
impaired as well.
Methods
A total of 203 male Sprague-Dawley rats weighing 360 to
450 g were used. The animals were housed in individual cages
and fed normal rat chow (Wayne Research Animal Diets,
Chicago, Illinois, USA) throughout the study. The diet con-
tained 1.4% calcium, 0.97% phosphorus, and 4.4 IU/g of
vitamin D. Studies were performed in five groups: (1) normal
rats; (2) rats with CRF of three and six weeks duration; (3)
normocalcemic parathyroidectomized CRF rats (CRF-PTX) of
three and six weeks duration, (4) CRF rats of three and six
weeks duration treated with verapamil (0.1 tg/g body wt) which
was given subcutaneously twice a day from day one of CRF,
(CRF-V), and (5) normal rats treated with verapamil, as de-
scribed above, for three and six weeks (normal-V).
CRF was produced by 5/6 nephrectomy; the animals under-
went right 2/3 nephrectomy through a flank incision, and a week
later a left nephrectomy was performed. PTX was performed by
electrocautery, and the success of the procedure was ascer-
tained by a decrease in serum levels of calcium of at least
2 mg/dl. The PTX rats were allowed to freely drink water
containing 5% calcium gluconate. This procedure is adequate to
normalize serum calcium in the PTX rats. Seven days after
PTX, the rats were subjected to 5/6 nephrectomy as described
above. Two days before sacrifice, the animals were housed in
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metabolic cages and two consecutive 24-hour urine collections
were obtained for the measurement of creatinine clearance. The
animals were killed by decapitation on day 21 or 42 after the
completion of the 5/6 nephrectomy in CRF rats (CRF, CRF-
PTX, CRF-V) or after the beginning of the treatment with
verapamil in normal rats.
Cardiac myocytes were isolated from ventricles using a
modification of the methods of De Young, Giannattasio and
Scarpa [181 and Haworth et al [19]. The details of the isolation
technique used in our laboratory have been reported [21. [Ca2]
in cardiac myocytes was measured by fura 2 AM using Perkin-
Elmer fluorometer model LS SB (Perkin-Elmer, Norwalk, Con-
necticut, USA). The details of this methodology have been
reported from our laboratory [2]. The dissociation constant for
Ca2-fura 2 was assumed to be 225 nM and calculation of
[Ca2]1 was made using the Grynkiewicz equation [201.
ATP content of cardiac myocytes was measured with an
high-performance liquid chromatography (Shimadzu Scientific
Instrument, Japan) system using 15-C Axion C18 column (5-/km
particle size; Cole Scientific, Calabasas, California, USA).
Measurement of Na-K ATPase and Ca2-ATPase activi-
ties were made using sarcolemmal vesicles of ventricles pre-
pared according to the method described by Pitts [21]. The
ventricles were washed, minced and homogenized in 0.6 M
sucrose, 10 mM imidazole-HC1, pH 7.0 (1 g tissue/3.5 ml
medium) in a Polytron homogenizer (Kinematic Instruments,
Switzerland), five times for 20 seconds each at 1600 rpm. The
homogenate was centrifuged at 12000 g for 30 minutes and the
pellet was discarded. The supernate was diluted (1 g tissue/5 ml)
with a medium containing 160 mi KC1, 20 mri 4-morpholinor-
propansulfonic acid (MOPS), pH 7.4, and was centrifuged with
ultracentrifuge (Beckman Instruments, Palo Alto, California,
USA) at 95000 g for 60 minutes. The resulting pellet was
resuspended in KC1-MOPS buffer and layered over a 30%
sucrose solution containing 0.3 M KCI, 50 mM sodium pyro-
phosphate and 0.1 M Tris-HC1, pH 8.3. After centrifugation at
95000 g for 90 minutes with swinging rotor (SW 28), the band at
the sucrose-buffer interface was aspirated and diluted with 3
volumes of KCI-MOPS solution. A final centrifugation at
95000 g for 30 minutes resulted in a pellet rich in sarcolemma.
An average yield of 5 to 7 mg protein/100 g of net tissue was
obtained. The pellet was resuspended in either KCI-MOPS
(KCI-loaded) or 160 NaCI-20 mri MOPS (NaCl loaded), pH 7.4
to provide 3 to 4 mg/ml and the mixtures were quickly frozen in
liquid nitrogen and stored at —70°C for up to one to two weeks
for further studies. Lack of contamination of the sarcolemmal
vesicles by sarcoplamic reticulum was ascertained with NaN3
inhibition test. Indeed, the activity of MgATPase with and
without the presence of NaN3 was not different (144± vs. 147
16.3 smol Pilhr/mg protein, respectively).
For the measurement of Na-K ATPase, 50 p1 of KC1-
loaded sarcolemmal vesicles, were added to 900 /Ll of medium
containing 50 mM Tris-HCI (pH 7.4), 1 mri EDTA and 4 mM
MgCI, in the presence and absence of 100 mM NaC1 and 10 mM
KC1. The medium with NaCl and KCI contained 2 mM ouabain.
Both samples were pre-incubated for five minutes at 37°C;
thereafter, 50/Li of 80 m of Tris ATP were added to the
mixtures to give a final concentration of 4 mri ATP. The
mixtures were incubated in a water bath for 20 minutes at 37°C.
The ATP levels were measured by the firefly luciferase lumi-
nescence technique [221 using LAD 535 luminometer (Turner
Designs, Sunnyvale, California, USA) before and at the end of
the 20 minute incubation. The values of Na-K ATPase
activity were calculated as the difference between the ATP
levels consumed by the sarcolemmal vesicles during the 20
minute incubation in the presence and absence of NaCI and
KC1.
The sarcolemmal vesicle Ca2-ATPase activity was deter-
mined by continuous monitoring of ATP consumption using the
firefly luciferase luminescence technique [22]. An aliquot of 50
il of the KCI-loaded sarcolemmal vesicles was added to 900 p1
of medium containing 160 mrt KC1, 20 mrvi MOPS, 5 mM MgC12,
5 mM NaN3 and 0.2 mrvi EGTA without calcium and with
different concentrations of calcium 0.0619, 0.0717, 0.0855,
0.1055, 0.1387, 0.1615 and 0.1964 m that are equivalent to
0.100, 0.125, 0.167, 0.250, 0.500, 1.00 and 5.00 /kM free Ca2,
respectively. For the determination of free calcium concentra-
tion, the association constant of 4.47 x 106 was used for
Ca2-EGTA binding [23]. At the end of five minutes pre-
incubation at 37°C, 50 p1 of 20 m of Tris ATP were added to
the mixtures giving a final volume of 1 ml and a concentration of
ATP of 1 m. The mixtures were incubated for 20 minutes at
37°C. The Ca2-ATPase activity was calculated as the differ-
ence between the ATP consumption in the presence and ab-
sence of calcium. The Km for calcium was calculated using the
Lineweaver-Burk line generated from seven different concen-
trations of substrate.
The Na-Ca2 exchange was measured in sarcolemmal yes-
ides as Nat-dependent 45Ca2 uptake by a modification of the
method described by Bersohn et a! [24]. An aliquot of 5 p1 of
NaCI-loaded sarcolemmal vesicles was added to 245 p1 of
uptake media containing 160 mr.i KC1, 45Ca2 0.3 /kCi (specific
activity 10 to 40 mCi/mg calcium, Amershan, Arlington
Heights, Illinois, USA), 10 /LM CaC12, 20 mM MOPS (pH 7.4).
After different times of 5, 10, 15, 30, 60 and 90 seconds, 30 /Ll of
10 mrs EGTA (pH 7.4) were added, followed by 1 ml of ice-cold
1 mrt EGTA-KCI-MOPS to stop the reaction. An aliquot of 1 ml
was then taken from the mixture and passed through millipore
membrane filter (0.45 m, Millipore Corp., Bedford, Massachu-
setts, USA). The membranes were subsequently washed twice
with 2 ml of ice-cold 1 mri EGTA-KC1-MOPS. The membranes
were then placed in scintillation vials containing 10 ml of
scintillation fluid (Ecolite, ICN Biochemicals, Irvine, Califor-
nia, USA) and counted with Beckman LS 7000 scintillation
counter. K-loaded vesicles were treated in a similar manner.
The Na-dependent 45Ca2 uptake activity was calculated as
the difference between the uptake by NaC1-loaded vesicles and
KC1-loaded vesicles.
The measurement of calcium in the plasma was made by
Perkin-Elmer atomic absorption spectrophotometer, model
503, and those of plasma creatinine and phosphorus and urine
creatinine by an autoanalyzer (Technicon Instrument Corp.,
Tarrytown, New York, USA). The serum levels of PTH were
determined by an INS-PTH immunoassay kit (Nichols Institute
Diagnostics, San Juan Capistrano, California, USA). This assay
recognizes the aminoterminal fragment of PTH. The lowest
detectable level is 3 pg/mi; the interassay variations is 7.3% and
the intra-assay variations 4%. Protein content of the sarcolem-
mal vesicles was measured by the method of Bradford [25].
Statistical analysis was done by one-way analysis of variance
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Table 1. Body weight, biochemical parameters and serum PTH levels in all groups of rats at the time of sacrifice
N
Body wt
g
Plasma mg/di Serum PTH
pg/mi
Creatinine clearance
pJ/min/100 gCreatinine Calcium Phosphorus
Normal 35 397 9.2 0.32 0.10 9.0 0.1 6.6 0.2 17 1.9 536 16.2
Studies at 3 weeks
CRF 8 314 5.5 1.11 0.06a 8.9 0.1 6.4 0.2 147 l2.Oa
CRF-PTX 8 308 9.1 1.01 o,osa 8.9 0.1 6.3 0.1 156 7.6a
CRF-V 9 328 6.3 1.00 0.loa 9.0 0.2 6.0 0.2 149 79
Normal-V 8 330 8.9 0.33 0.01 8.7 0.2 6.6 0.3 523 14.0
Studies at 6 weeks
CRF 32 397 7.0 1.13 0.lOa 8.7 0.2 6.8 0.3 54 6.6a 156 6.25a
CRF-PTX 30 401 6.6 1.01 0.03a 8.6 0.2 6.8 0.2 11 4.3 162 l1.l
CRF-V 35 408 8.0 1.02 o,lIa 9.0 0.2 6.7 0.3 49 4,7a 159 10.5
Normal-V 38 387 5.0 0.33 0.01 8.9 0,2 6.9 0.5 20 4.6 546 13.1
Data are presented as mean SE.
aP < 0.01 vs. other groups
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Fig. 1. Base! levels of cytosolic calcium in cardiac myocytes of nor-
mal, CRF, CRF-PTX, CRF-V and normal-V rats. Each datum point
represents one rat and brackets denote 1 SE. Open symbols are values
after 3 weeks and closed symbols after 6 weeks of study. The values
after 3 and 6 weeks of CRF are significantly (P < 0.01) higher than all
other groups.
and Tukey's honest statistical difference test for multiple com-
parison between the groups. Data are presented as mean SE.
Results
Table 1 provides for the effects of the various experimental
procedures on body weight, plasma concentrations of creati-
nine, calcium and phosphorus, the serum concentrations of
PTH and creatinine clearance. There were no significant differ-
ences in body weight among the rats studied at three weeks and
among those studied at six weeks. The plasma concentration of
calcium and phosphorus among the various groups of animals
were also not different. The plasma concentrations of creatinine
were significantly (P < 0.01) higher and the creatinine clear-
ances were significantly (P < 0.01) lower in CRF, CRF-PTX
and CRF-V rats than in normal and normal-V animals. There
were no significant differences between these parameters
among CRF, CRF-PTX and CRF-V rats. The serum concentra-
tion of PTH was significantly (P < 0.01) higher in CRF and
CRF-V rats than in normal, normal-V and CRF-PTX animals.
Figure 1 depicts the basal levels of [Ca2] in cardiac myo-
cytes in all groups of animals after three and six weeks of the
study. The [Ca2]1 in cardiac myocytes after three weeks of
Normal CRF CRF-PTX CRF-VER NOR-VER
Fig. 2. ATP content of cardiac myocyles from normal, CRF, CRF-
PTX, CRF-V, and normal-V rats. Each datum point represents one rat
and brackets denote 1 SE. Open symbols are values after 3 weeks and
closed symbols after 6 weeks of study. The values after 3 and 6 weeks
of CRF are significantly (P < 0.01) lower than in other groups.
CRF (82 0.6 nM) was significantly (P < 0.01) higher than in
cells from normal rats (63 1.6 nM). The basal levels of [Ca2]
increased to higher levels (P < 0.01) after six weeks of CRF
(105 3.0 nM). PTX of CRF rats and their treatment with
verapamil prevented the rise in [Ca2}1 of cardiac myocytes.
Treatment of normal rats with verapamil did not affect the
[Ca2411 of their cardiac myocytes. Indeed, the basal levels of
[Ca2]1 of cardiac myocytes from CRF-PTX after three and six
weeks of study (60 2.0 and 59 1.5 nM), CRF-V (60 1.9
and 63 3.2 nM) and normal-V (58 2.5 and 59 2.6 nM) rats
were not different from values of normal cardiac myocytes.
The ATP contents of cardiac myocytes after three weeks of
CRF (210 20.4 nmol/106 cells) were significantly lower (P <
0.01) than those observed in normal rats (353 16.2 nmoIJlO6
cells; Fig. 2). There was a further decline in ATP content of
cardiac myocytes to 114 8.9 nmolIlO6 cells after six weeks of
CRF. The values of ATP content after three and six weeks
of study in cardiac myocytes from CRF-PTX (385 19.4 and
365 21.1 nmolJlO6 cells), CRF-V (372 28.7 and 396 22.1
nmolllO6 cells) and normal-V (383 15.1 and 363
17.2 nmolIlO6 cells) were not different from those in normal
cardiac myocytes.
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Fig. 3. A representative study oft he Km for calcium of Ca-ATPase of
sarcolemmal vesicles of cardiac myocytes. Symbols are: 0, r = 0.95,
Km = 0.34), (•, r = 0.98, Km = 0.52 jiM) (U, r = 0.95, Km = 0.30 jiM)(U, r = 0.99; Km = 0.27 jiM) (, r = 0.97, Km = 0.29 jiM). The data
are presented as the Lineweaver-Burk plot demonstrating linearity. The
plot represents reciprocal of initial velocity (V) versus the reciprocal of
the initial concentration of the substrate(S) which yields a line where
sloope is Kflh/Vmax, whose Y intercept is llVmax and whose X intercept
is -I/Km.
Figures 3 and 4 depicts the values of Vmax and Km of
Ca2-ATPase of cardiac sarcolemmal vesicles. After six weeks
of CRF, the values of the Vmax of Ca2-ATPase (2.97 0.38
jimol/Pi/hr/mg protein) were significantly (P < 0.01) lower and
those of its Km (0.537 0.068 M) were significantly (P < 0.01)
higher than the normal values (6.10 0.29 prnol Pi/hr/mg
protein and 0.284 0.037 jiM); PTX of CRF rats and their
treatment with verapamil prevented the changes in the Vmax
and Km of this enzyme. These values in CRF-PTX, CRF-V and
normal verapamil rats were not different from the normal
values.
The values of the max of Na-K-ATPase of cardiac sar-
colemmal vesicles from hearts with six weeks of CRF rats
(10.2 0.7 jimol Pi/hr/mg protein) were significantly (P < 0.01)
lower than the normal values (16.9 0.73 /Lmol Pilhr/mg
protein; Fig. 5). The values of the Vmax of this enzyme in
CRF-PTX and CRF-V rats were not different from normal
values despite CRF. Treatment of normal rats with verapamil
did not affect the 'Tmax of Na-K ATPase of cardiac sarcolem-
mal vesicles.
The Na-dependent 45Ca2 uptakes by cardiac sarcolemmal
vesicles in all groups of animals studied are shown in Figure 6.
Only CRF animals displayed significantly (P < 0.01) lower
levels of uptake at all times of the uptake study. The values of
Na-Ca2 exchange are shown in Table 2. These values in CRF
animals were significantly (P < 0.01) lower than in all other
groups of rats. The values of the Na-Ca2 exchange among the
normal, CRF-PTX, CRF-V and normal-V rats were not differ-
ent.
0
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FIg. 4. The values of the V,,, and Km for calcium of Ca'-ATPase of
sarcolemmal vesicles of cardiac myocytes in the various groups of
animals studied. Symbols are: (LI, normal, (U) CRF; () CRF-PTX;
() CRF-V; (lUll) NOR-V. bracket denotes 1 SE. < 0.01 versus all
groups.
Discussion
The results of the present study demonstrate that the basal
levels of [Ca2]1 of cardiac myocytes are elevated in CRF and
this derangement is mediated by the state of secondary hyper-
parathyroidism of CRF. This conclusion is supported by the
finding that the levels of [Ca2] of cardiac myocytes from
normocalcemic CRF-PTX rats are normal. Further, the treat-
ment of CRF rats with the calcium channel blocker, verapamil,
which interferes with the PTH-induced entry of calcium into
cardiac myocytes [2] also prevented the rise in [Ca2]1. This
finding of increased basal levels of [Ca2]1 in cardiac myocytes
is in agreement with previous observations demonstrating in-
creased calcium content in the hearts of rats [4, 5], dogs [261 and
humans [27] with CRF.
The findings of the present study are similar to those ob-
served in pancreatic islets [14], polymorphonuclear leukocytes
[15], brain synaptosomes [161, B cells [17], thymocytes [281 and
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Normal CRF CRF-PTX CRF-VER NOR-VER
Fig. 5. The Vm,,,, of Na-K4ATPase of animals studied. Each column
represents one rat and brackets denotes I SE. The values in CRF rats
are significantly (P < 0.01) lower than all other groups.
Time, seconds
Fig. 6. Time course of Na1-dependent 45Ca2 uptake by sarcolemmal
vesicles of cardiac myocytes in the various grous of animals. Each
datum point represents the mean values obtained in 6—8 rats and the
brackets denotes I SE. Symbols are: () normal; (I) CRF; (0)
CRF-PTX; () CRF.V; (0) V; (A) KCI-vesicles.
platelets [29]. Taken together, the available data and the results
of the present study support the notion that CRF is a state of
generalized increase of calcium burden in cells.
Our data also show that the rise in [Ca2]1 in cardiac
myocytes is a progressive process, and [Ca2]1 increases fur-
ther as the duration of CRF advances. A similar phenomenon
was also reported in pancreatic islets from CRF rats [30]. In
these studies, [Ca2], of pancreatic islets was measured weekly
for six weeks after the induction of CRF; it was found that
[Ca2]1 began to rise at week 3 of CRF and continued to
increase thereafter, reaching a plateau at week 6 of CRF.
PTH augments calcium entry into cardiac myocytes in a dose
dependent manner [2]. One can, therefore, suggest that the
increase in the basal levels of [Ca2], of the myocytes in CRF is
primarily due to this action of the hormone. However, such an
event, by itself, should not increase basal levels of [Ca2]1,
Na-Ca2 cxchange nmol Ca'/mg
N
protein
15 seconds 60 seconds
Normal 8 5.83 0.29 7.67 0.33
CRF 7 2.98 0.l9a 4.12 0.4O
CRF-PTX 7 5.10 0.31 7.59 0.62
CRF-V 6 5.18 0.16 7.22 0.42
Normal-V 8 5.43 0.34 7.55 0.27
since cardiac myocytes, as other cells, are endowed with
mechanisms that allow them to pump excess calcium out of the
cell and/or buffer it by intracellular organelles [31, 32]. There-
fore, one must conclude that in CRF, calcium extrusion out of
the cells and/or its buffering by subcellular structure is also
impaired.
The processes responsible for calcium extrusion out of the
cell utilize sarcolemmal Ca2-ATPase, Na-Ca2 exchange and
Na-K ATPase [31, 32]. Our data show that the Vmax of
Ca2-ATPase is reduced, and its Km is increased and Na-
Ca2 exchange activity and the Vmax Of Na-K ATPase are
impaired in CRF. These observations indicate that both in-
creased entry of calcium into the cardiac myocytes and reduced
calcium efflux from these cells are responsible for the elevation
in their basal levels of [Ca2]1. The data are also consistent with
the notion that the initial event leading to the rise in [Ca2] is
the PTH-induced entry of calcium in the cardiac myocytes. This
action would then trigger other cellular events that lead to a
decrease in calcium extrusion. Such a proposition is supported
by the findings that both PTX of CRF rats, which abolishes the
state of secondary hyperparathyroidism, or the treatment of
CRF rats with verapamil, which blocks the PTH-mediated entry
of calcium into cells, prevented the abnormalities in the pro-
cesses responsible for calcium extrusion out of the cardiac
myocytes. Thus, neither elevated PTH per se (CRY-V rats) nor
CRF per se (CRF-PTX rats) adversely affects the activity of
Ca2-ATPase, Na-Ca2 exchange or Na-K ATPase.
Chronic and sustained entry of calcium into cells is associ-
ated with inhibition of mitochondrial oxidation, and hence
reduced ATP production [33—35]. Both Ca2-ATPase and
Na-K ATPase requires ATP [31, 32], and the fall in ATP
content of the cardiac myocytes is, at least partly, responsible
for the reduced Ymax of these enzymes. The changes in the
Ym of Ca2-ATPase and Na-KATPase could be due to
changes in the number of enzyme units per cell, changes in the
activity of each enzyme unit or both. Our data do not differen-
tiate between these possibilities.
The mechanisms responsible for the inhibition of the activity
of the Na-Ca2 exchanger are not elucidated by the present
study. The modulation of the cardiac Na-Ca2 exchange is
complex and not well understood [36]. It has been reported that
the inhibition of Na-KATPase may produce acidosis in
cardiac muscle [37], and a fall in cell pH inhibit the Na
dependent Ca2 efflux [38]. It is, therefore, possible that the
inhibition of the Na-KATPase activity of the cardiac sar-
colemmal vesicles of rats with CRF contributes to the inhibition
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Table 2. Na-Ca2 exchange by cardiac sarcolemmal vesicles from
normal, CRF, CRF-PTX, CRF-V and Normal-V rats
Data are mean SE.
a P < 0.01 vs. all other groups
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of Na-Ca2 exchanger. The role of ATP in modulating the
Na-Ca2 exchange in cardiac cells is not established, and,
therefore, one cannot attribute the inhibition of the activity of
Na-Ca2 exchanger observed in our study to the reduction in
the ATP content in the cardiac myocytes of CRF rats.
The data of the present study and those reported previously
by us [2] support the proposition that the rise in the basal levels
of [Ca2] of cardiac myocytes is mediated by the sequence of
events depicted in Figure 7. The initial step in this process is the
elevated blood levels of PTH in CRF. The chronic excess PTH
stimulate G proteins in cardiac myocytes with consequent
activation of L-type calcium channels. This is followed by
influx of calcium into these cells. The continuous PTH-medi-
ated calcium entry into the cardiac myocytes inhibits mitochon-
drial oxidation and ATP production. The fall in ATP contributes
to the impairment in the activities of Ca2-ATPase and Na-
KATPase. The change in the latter may result in a fall in the
pH of the cardiac myocytes with consequent inhibition of the
NatCa2 exchanger. Calcium extrusion is reduced due to
impaired activities of Ca2-ATPase, Na-Ca2 exchanger and
Na-KATPase. Thus, both increased entry of calcium into
cardiac myocytes and reduced exit of this ion from these cells
result in calcium accumulation in them. This formulation has
clinical implications since the prevention of secondary hyper-
parathyroidisni in CRF or the use of calcium channel blockers
would prevent calcium accumulatiohn in myocardium, and
consequently ameliorate cardiac dysfunction in uremia. Indeed,
limited data in dialysis patients demonstrated the beneficial
effect of subtotal parathyroidectomy [7] or the medical suppres-
sion of the parathyroid gland activity [39] on their myocardial
dysfunction of these patients. In addition, the treatment of
dialysis patients with verapamil was followed by improvement
in their myocardial function [401.
It should be mentioned that Bacskai and Friedman [41]
reported that PTH may induce the recruitment of new dihydro-
pyridine-sensitive calcium channels in the cultured distal tubu-
lar cells. A similar phenomenon may be operative in cardiac
myocytes as well. However, the heart is an excitable tissue and
possess L-type calcium channels which most likely are acti-
vated by PTH.
Fig. 7. A schematic presentation of the
sequence of events that lead to the elevation
in [Ca2 7 of cardiac myocytes. All steps
denoted by solid arrow have been tested
either in the present study or in a previous
study [2] from our laboratory. The interrupted
arrow represents proposed pathways but not
tested by the present study.
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